The Food and Drug Administration on Wednesday approved the second in a radically new class of treatments that genetically reboot a patient’s own immune cells to kill cancer.
{iframe}https://www.nytimes.com/2017/10/18/health/immunotherapy-cancer-kite.html{/iframe}